Company intelligence / Profile preview
Belmedpreparaty
- Ownership
- Private
- Development stage
- Other
Overview
Belmedpreparaty is Belarus’s leading pharmaceutical manufacturer, producing approximately 360 products, including insulin (the only producer in Belarus), anticancer agents, antibiotics, narcotics/psychotropic substances, and drugs for tuberculosis and other major diseases. Its portfolio covers almost all dosage forms and key products are approved and supplied domestically and to at least 14 export markets[1][2][4].
- Therapeutic areas
- OncologyInfectious DiseasesEndocrinologyPsychiatry
- Modalities
- Small moleculeBiologicProtein
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Belmedpreparaty.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Belmedpreparaty.